论文部分内容阅读
目的观察芪归健脑方对阿尔茨海默病(AD)病人血浆中乙酰胆碱酯酶(AChE)活性和认知能力的影响。方法选取AD病人60例,随机分为两组:芪归健脑方组和西药治疗组,各30例。芪归健脑方组口服芪归健脑方,每次100g,每日2次。西药治疗组口服吡拉西坦(脑复康),每次0.8g,每日3次。两组均连续治疗6个月,治疗前后分别测定血浆中AChE活性,并应用简易智力状态量表评估智力障碍程度。结果两组治疗后AChE活性和简易智力状态量表积分较治疗前均明显增加(P<0.05),但两组间治疗后比较差异均无统计学意义(P>0.05)。结论芪归健脑方能提高AD病人血浆中AChE的活性,并且能明显改善其认知能力。
Objective To observe the effect of Qigui Jiannao Recipe on plasma AChE activity and cognitive ability in patients with Alzheimer’s disease (AD). Methods Sixty AD patients were selected and randomly divided into two groups: Qigui Jiannaofang group and western medicine group, with 30 cases in each group. Qigui Jiannao group oral Qi Qijian brain, each 100g, 2 times a day. Western medicine treatment group oral piracetam (Naofukang), each 0.8g, 3 times a day. The two groups were treated for 6 months continuously, before and after treatment were measured in plasma AChE activity, and the use of simple mental status scale assessment of mental retardation. Results The scores of AChE activity and simple mental status after treatment in both groups were significantly higher than those before treatment (P <0.05), but there was no significant difference between the two groups after treatment (P> 0.05). Conclusion Qigui Jiannao can improve AChE activity in plasma of patients with AD, and can significantly improve its cognitive ability.